Open Access10.1002/ANBR.202100109
Lipid Nanoparticles for Drug Delivery
Letao Xu,Xing Wang,Yun Liu,Guangze Yang,Robert J. Falconer,Chun-Xia Zhao,Chun-Xia Zhao +6 more
- 25 Nov 2021
- pp 2100109
258
About: The article was published on 25 Nov 2021. and is currently open access. The article focuses on the topics: Solid lipid nanoparticle & Drug delivery.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Design, optimization & characterization of niosomal & polymeric nanoparticles
Fatima Tariq,Muhammad Zaman,Muhammad Ahsan Waqar,Muhammad Asad Saeed,Rai Muhammad Sarfraz +4 more
- 03 Nov 2023
TL;DR: Niosomal and polymeric nanoparticles offer targeted drug delivery, reduced toxicity, and high drug loading capacity, with applications in cancer therapy, gene therapy, and vaccination, but require careful material selection and optimization for efficient delivery.
Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy
Josef Jampilek,Katarina Kralova +1 more
TL;DR: In this article, the authors provide an overview of the development of TKIs for the treatment of cancer and their mechanism of action and summarizes the results of the applications of self-nanoemulsifying drug delivery systems, nanoemulsions, liposomes, solid lipid nanoparticles, lipid-polymer hybrid nanoparticles and nanostructured lipid carriers.
Microfluidic-enabled aptamer-modified liposomal probes for targeted transient triplet differential photoacoustic imaging
Zeyu Chen,Mingde Zheng,Yang Xie,Qi Sun,Changling Lv,Qibo Lin,Maike Chen,Shan Han +7 more
Structural and componential design: new strategies regulating the behavior of lipid-based nanoparticles in vivo.
TL;DR: In this paper , the authors review the development of lipid-based nanoparticles, from simple self-assembled nanicle-structured liposomes to multifunctional lipid nanoparticles and summarize strategies that regulate their tissue distribution, cell internalization, and drug release.
Osmoimpregnation of chayote (Sechium edule (Jacq.) Sw.) with piperine using macro and nanometer-sized emulsions
Karina Huerta Vera,María de Lourdes Catalina Arévalo Galarza,Adriana Contreras Oliva,Luz Alicia Pascual Pineda,Maribel Jiménez Fernández,Ricardo Salazar,Marisol Castillo Morales,Enrique Flores Andrade +7 more
References
U1 snRNP regulates cancer cell migration and invasion in vitro
Jung-Min Oh,Christopher C. Venters,Chao Di,Anna Maria Pinto,Lili Wan,Ihab Younis,Zhiqiang Cai,Chie Arai,Byung Ran So,Jingqi Duan,Gideon Dreyfuss +10 more
TL;DR: An unexpected role for U1 homeostasis (available U1 relative to transcription) in oncogenic and activated cell states is revealed, and U1 is suggested as a potential target for their modulation.
Nano based drug delivery systems: recent developments and future prospects
Jayanta Kumar Patra,Gitishree Das,Leonardo Fernandes Fraceto,Leonardo Fernandes Fraceto,Estefania Vangelie Ramos Campos,Estefania Vangelie Ramos Campos,Maria del Pilar Rodriguez-Torres,Laura Susana Acosta-Torres,Luis A. Diaz-Torres,Renato Grillo,Mallappa Kumara Swamy,Shivesh Sharma,Solomon Habtemariam,Han-Seung Shin +13 more
TL;DR: An updated summary of recent advances in the field of nanomedicines and nano based drug delivery systems through comprehensive scrutiny of the discovery and application of nanomaterials in improving both the efficacy of novel and old drugs and selective diagnosis through disease marker molecules is presented.
Engineering precision nanoparticles for drug delivery
Michael J. Mitchell,Margaret M. Billingsley,Rebecca M Haley,Marissa E. Wechsler,Nicholas A. Peppas,Robert Langer +5 more
TL;DR: Advances in nanoparticle design that overcome heterogeneous barriers to delivery are discussed, arguing that intelligent nanoparticles design can improve efficacy in general delivery applications while enabling tailored designs for precision applications, thereby ultimately improving patient outcome overall.
Doxil®--the first FDA-approved nano-drug: lessons learned.
TL;DR: This review summarizes historical and scientific perspectives of Doxil development and lessons learned from its development and 20 years of its use and demonstrates the obligatory need for applying an understanding of the cross talk between physicochemical, nano-technological, and biological principles.
3.9K
Nanocapsule formation by interfacial polymer deposition following solvent displacement
TL;DR: In this paper, an attempt was made to elucidate the mechanisms of formation in terms of interfacial turbulence between two unequilibrated liquid phases involving flow, diffusion and surface tension decrease (Marangoni effect).
2.2K